PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹892 Cr | ₹1,005 Cr | ₹484 Cr | ₹766 Cr | ₹598 Cr |
What is the latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹892 Cr |
| Mar2024 | ₹1,005 Cr |
| Mar2023 | ₹484 Cr |
| Mar2022 | ₹766 Cr |
| Mar2021 | ₹598 Cr |
How is Cash Flow from Operating Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹892 Cr | -11.17 | |
| Mar2024 | ₹1,005 Cr | 107.60 | |
| Mar2023 | ₹484 Cr | -36.86 | |
| Mar2022 | ₹766 Cr | 28.25 | |
| Mar2021 | ₹598 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,019.7 Cr | -0.9% | -10% | -18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.1% | -2.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | -0.2% | -2.8% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 2.3% | 1.2% | 41.1% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 1.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | 0.1% | -2.4% | 2.3% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -0.9% |
-10% |
-18.9% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses